We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Heiq Plc | LSE:HEIQ | London | Ordinary Share | GB00BN2CJ299 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.23 | -2.54% | 8.82 | 9.10 | 9.48 | 8.82 | 8.82 | 8.82 | 167,213 | 13:32:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 48.1M | -29.25M | -0.2081 | -0.42 | 12.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/9/2021 12:52 | No bottom insight (imo) In a Swiss analogy we have fallen off the North face of the Eiger but only at the top of the White Hare ski run with a very steep black run still to descend with probability of many falls on the way. This note especially crafted for Heiq managment - That is if they pay any attention to BB's until they combe back with the begging bowl!! | pugugly | |
29/9/2021 12:37 | Where is bottom? Down another 7.5% | mrbeaky | |
29/9/2021 09:50 | Pugugly. I'm not surprised . PS is an ex plc accountant. The figures are pretty sad to say the least. Must remember any story that starts with two guys going for a walk up a mountain and decide to form a company Avoid. Remember Angel mining? That was some trekkers bright idea to reopen an abandoned gold mine in a very unaccessible side of a mountain in Greenland. That froze over again long before the Greenland government decided to ban all future mineral exploration. Hope it works out if you're staying, I think I'll be chilling somewhere else thanks | earwacks | |
29/9/2021 09:30 | Stockopedia - Still very negative this morning - | pugugly | |
28/9/2021 21:33 | Chill guys - buy one of their products to stop you getting hot under the collar. This remains a long term winner. | edwardt | |
28/9/2021 17:37 | I quit at £1.34 with a small profit. Seems to me many of the tip-sheet stocks that fuel pi imagination underestimate supply-chain, raw material issue and cost inflation, etc. Apart from one Animalcare, whose interim results today were very good and share price rise as expected of a stock with limited free-float) I have switched to life insurers and ilk as their growth and revenue comes from document-oriented products that are easily transportable and simply require the transfer of funds from buyer to seller. | trcml | |
28/9/2021 17:16 | I sold after presentation. To try and tell us growth is on track after issuing a profit warning and then no real guidance on full year earnings, just a lot of ifs buts and maybes is not my idea of a CEO in control. Not blaming him particularly, the economy is where it is and it seems that although they have some great ideas they haven't been able to evidence there is a market for many of these ideas any where near close to previous valuation. There is no growth, its backwards. Someone asked if it was possible to buy any of their products in British supermarkets.Answer no, but you can in Swiss ones. Maybe they should have listed there instead. They are relying on partners to buy their products to sell but clearly there are supply chain issues as well as rapid increases in production costs much of which cannot yet be passed on to clients because of obligations to contracts. Unbelievable! This is news driven stock. The good news was they sold loads of masks and ppe equipment. Now they don't or much of anything else by the sounds of it. Wasn't going to hang around for the next update in six months. I could probably write it for them now. As for attracting institutional investors, best of luck | earwacks | |
28/9/2021 16:17 | @Dr B - hope your portfolio isn't HEIQ & GOG ;) Has to be a crash eventually - look at the farcical valuations in anything tech - but a brave man to call it. Feels like the usual Sept/Oct wobbles to me, before a run-up to Christmas. Place your bets.. | spectoacc | |
28/9/2021 16:15 | I've cut my losses here and exited. Not impressed with the results. | impvesta | |
28/9/2021 16:15 | I’m 40% cash, feel the US is stupidly overvalued and if/when it corrects it will take us down. Sept has been a horrible month for me, absolute sea of red today too | dr biotech | |
28/9/2021 15:58 | I am put off to add here- as we seem to be entering a tumultuous episode on the market- tech heavily down | ali47fish | |
28/9/2021 15:34 | seems to have stagnated - let's see what tomorrow brings | wall street trader | |
28/9/2021 11:39 | There appears to be a big buyer around the £1 level. Just did a dummy sell order for 10,000 shares and was offered £1. It's turned. | jurgenklopp | |
28/9/2021 11:38 | WST - ditto, although I did manage some at 98 GLA SR | stockriser | |
28/9/2021 11:31 | hard to disagree with that. | edwardt | |
28/9/2021 11:30 | ok I'm in at 100 expect a turnaround from here | wall street trader | |
28/9/2021 11:28 | Some good points 74tom but I don't agree that "Viroblock sales gave 2021 profitability a one off boost". I think that we are going to be kicking variations on the Covid theme around for the forseeable future. General standards of hygeine are so appalling at present, Florence Nightingale must be turning in her grave. People who have grown up with anti-biotics have little or no regard for personal hygeine, and that includes, I'm sorry to say, a lot of the nursing profession. Our addiction to foreign travel makes the likelihood of something else spreading rapidly inevitable imho. | melton john | |
28/9/2021 11:11 | Skids really under this- Not sure how many followers of Sharewatch who tipped at much higher price of 171/173 so may well still be bailing out if not already cut losses but volume seems too high tip sheet holders - Suspect some of the original placees now regretting and cutting losses. | pugugly | |
28/9/2021 10:30 | I wondered who asked about Heiq getting 15% of the entire textiles market and what it would be worth. Might as well ask the Watford manager about signing Mbappe. I’d have asked whether they will be more communicative going forward - why weren’t these figures given in a trading update etc. Not a good day for me, red everywhere. | dr biotech | |
28/9/2021 10:23 | 74tom _ very fair points - Another possible problem (imo) is that they are juggling too many products all of which appear to have very consumer and trade attractive USP's and I wonder if they do not have sufficient resources to but behind all of them - I would be happier if they used more of a rifle approach rather than the apparent shot gun one. | pugugly | |
28/9/2021 10:09 | The problem I have with the current HEIQ valuation is that pre Covid they had a slow growth rate & were barely profitable. Viroblock sales gave 2021 profitability a one off boost which they took advantage of via an IPO in which shareholders sold some £40m of stock. Now we have a somewhat predictable flattening of revenue, increase in costs and lowering of gross margins and for the first time the share price is now lower than the 112p IPO. The question is what should HEIQ be valued at? I think this stock will be heavily sentiment driven, with successful innovations like Viroblock leading to lumpy revenue growth that will often be very difficult to predict. As confirmed in the investor meet company presentation this morning, the issues that caused the H1 miss are set to continue, with a 4th Covid wave in Asia a particular problem for them. I therefore expect HEIQ to fall below £1 over the coming weeks, likely coming to rest at somewhere near the £100m market cap level (77p). At this level I'd likely buy a starter position. I enjoyed listening to management answer investor questions, in particular when the CMO added additional colour around certain product launches & emphasised the question about why the share price had fallen so much, refreshing to hear compared to the wooden behaviour of some companies. | 74tom | |
28/9/2021 09:58 | Melton John, you're crazy! :-) | glavey | |
28/9/2021 09:51 | Interesting webinar. Graphene battery and medical coatings could be key drivers in the future, plus may start seeing detergent additives in standard products. Headwinds due to pandemic supply chain issues look like persisting. Sold some at open and taken a hit this morning, but will keep the rest. Long term looks like a decent play, but that could be years. | dr biotech | |
28/9/2021 09:24 | I think value will be extracted from their IP, either themselves or by takeover or sale. | dibbs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions